National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

Velcade (VEL-kayd)

 A drug used to treat multiple myeloma that has gotten worse during treatment with other anticancer drugs. It is also used to treat mantle cell lymphoma in patients who have already received at least one other type of treatment. Velcade is also being studied in the treatment of other types of cancer. It is a type of proteasome inhibitor and a type of dipeptidyl boronic acid. Also called bortezomib and PS-341.



Previous Definitions:VEGFR tyrosine kinase inhibitor, VEGFR-2 inhibitor CT-322, vein, velafermin, Velban
Next Definitions:venipuncture, venlafaxine, venography, venous sampling, ventilator

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov